SCHEMBL6512477

SCHEMBL6512477

c1ccc(CCN2CCc3ccccc3C2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.68
HTR1A P08908 3/20 0.60
HTR2A P28223 3/20 0.60
HTR7 P34969 3/20 0.60
DRD3 P35462 3/20 0.60
HTR2B P41595 3/20 0.60
DRD2 P14416 2/20 0.60
HRH1 P35367 2/20 0.60
SLC6A4 P31645 1/20 0.60
KDM4E B2RXH2 1/20 0.59
ALDH1A1 P00352 1/20 0.59
GRIN2B Q13224 1/20 0.59
HTR2C P28335 1/20 0.59
ACHE P22303 1/20 0.58
SIGMAR1 Q99720 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24349700 0.87 ABCB1 (0.70) HRH3HTR1AHTR2AHTR7DRD3
SCHEMBL1585063 0.87 SLC6A3 (0.61) HRH3HTR1ADRD3DRD2ACHE
Hydrochloric Acid SCHEMBL7600991 0.85 ABCB1 (0.68) HRH3HTR1AHTR2AHTR7DRD3
SCHEMBL16061507 0.85 ABCB1 (0.64) HTR1AHTR2AHTR7DRD3HTR2B
SCHEMBL28595944 0.83 HRH3 (0.51) HRH3HTR1AHTR2AHTR7DRD3
SCHEMBL8491977 0.83 DRD2 (0.59) HRH3HTR1AHTR2AHTR7DRD3
SCHEMBL6489547 0.83 ABCB1 (0.53) HRH3SIGMAR1
SCHEMBL31174282 0.83 PRMT5 (0.56) HRH3HTR1AHTR2AHTR7DRD3
SCHEMBL31134754 0.81 ACHE (0.66) HTR2BHRH1KDM4EALDH1A1ACHE
SCHEMBL10978742 0.81 ACHE (0.66) HTR2BHRH1KDM4EALDH1A1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005077885-A1 RUTHENIUM-CATALYZED HYDROAMINATION OF OLEFINS YALE UNIVERSITY (US) 2005-08-25 WO disclosed
WO-1999024022-A2 ISOQUINOLINE DERIVATIVES FOR TREATING DISORDERS ASSOCIATED WITH 5HT7 RECEPTORS F. HOFFMANN-LA ROCHE AG (CH) 1999-05-20 WO disclosed